Literature DB >> 8427523

Use of cyclosporin A in the eosinophilia myalgia syndrome.

D J Clauw, J A Alloway, P Katz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8427523      PMCID： PMC1004964          DOI： 10.1136/ard.52.1.81-b

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Postmortem studies of the heart in three fatal cases of the eosinophilia-myalgia syndrome.

Authors:  T N James; M L Kamb; G A Sandberg; R M Silver; E M Kilbourne
Journal:  Ann Intern Med       Date:  1991-07-15       Impact factor: 25.391

2.  Characterization of contaminants in EMS-associated L-tryptophan samples by high-performance liquid chromatography.

Authors:  T Toyo'oka; T Yamazaki; T Tanimoto; K Sato; M Sato; M Toyoda; M Ishibashi; K Yoshihira; M Uchiyama
Journal:  Chem Pharm Bull (Tokyo)       Date:  1991-03       Impact factor: 1.645

3.  Dyspnea and pulmonary function in the L-tryptophan-associated eosinophilia-myalgia syndrome.

Authors:  C A Read; D Clauw; C Weir; A T Da Silva; P Katz
Journal:  Chest       Date:  1992-05       Impact factor: 9.410

4.  Eosinophilia-myalgia syndrome. Results of national surveillance.

Authors:  L A Swygert; E F Maes; L E Sewell; L Miller; H Falk; E M Kilbourne
Journal:  JAMA       Date:  1990-10-03       Impact factor: 56.272

5.  Recurrent respiratory insufficiency and depressed ventilatory drive complicating mitochondrial myopathies.

Authors:  R J Barohn; T Clanton; Z Sahenk; J R Mendell
Journal:  Neurology       Date:  1990-01       Impact factor: 9.910

6.  An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use.

Authors:  E A Belongia; C W Hedberg; G J Gleich; K E White; A N Mayeno; D A Loegering; S L Dunnette; P L Pirie; K L MacDonald; M T Osterholm
Journal:  N Engl J Med       Date:  1990-08-09       Impact factor: 91.245
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.